DrugPatentWatch Database Preview
Drugs in Development Information for Naproxcinod
What is the drug development status for Naproxcinod?
Naproxcinod is an investigational drug.
There have been 9 clinical trials for Naproxcinod.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2005.
The most common disease conditions in clinical trials are Osteoarthritis, Hypertension, and Osteoarthritis, Knee. The leading clinical trial sponsors are NicOx and [disabled in preview].
Summary for Naproxcinod
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 12 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2005-12-01) |
| Vendors | 19 |
Recent Clinical Trials for Naproxcinod
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male | NicOx | Phase 1 |
| Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide | NicOx | Phase 1 |
| A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function | NicOx | Phase 1 |
Clinical Trial Summary for Naproxcinod
Top disease conditions for Naproxcinod
Top clinical trial sponsors for Naproxcinod
US Patents for Naproxcinod
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
